This is a preview of subscription content, log in via an institution to check access.
Notes
The annual American Society of Clinical Oncology (ASCO) meeting was held in Atlanta, GA, in June.
References
Bayer Healthcare. Serum HER-2/neu change predicts clinical out-come to trastuzumab-based therapy. Media release: 3 Jun 2006
University Hospitals of Cleveland. Researchers announce new predictor for lung cancer treatment and survival. Media release: 5 Jun 2006
Eli Lilly and Company. Lilly breast cancer studies explore potential role of pharmacogenomics in customizing chemotherapy. Media release: 3 Jun 2006
Eli Lilly and Company. Lilly announces phase II results for Alimta® in first-line metastatic breast cancer trial. Media release: 4 Jun 2006
Rights and permissions
About this article
Cite this article
Diagnostic Developments. Pharmaceutical & Diagnostic Innovation 4, 18–19 (2006). https://doi.org/10.1007/BF03259654
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03259654